ISSN: 2576-3881

Journal of Cytokine Biology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Cytokine Biol 8: 463,
  • DOI: 10.4172/2576-3881.1000463

Harnessing the Power of Cytokine Inhibitors: A Breakthrough in Immunotherapy

Kaif Iqbal Ahemad*
Department of Immunology, Medical College of Kabul, Afghanistan
*Corresponding Author : Kaif Iqbal Ahemad, Department of Immunology, Medical College of Kabul, Afghanistan, Email: Kaif.ia@gmail.com

Received Date: Sep 01, 2023 / Accepted Date: Sep 28, 2023 / Published Date: Sep 28, 2023

Abstract

Cytokine inhibitors, a class of pharmaceutical agents, have emerged as a promising approach in the field of immunotherapy. These inhibitors target cytokines, pivotal signaling molecules in the immune system, to modulate immune responses. This article provides an overview of cytokine inhibitors, their mechanisms of action, and their clinical applications, shedding light on their role in treating autoimmune diseases, inflammatory conditions, and cancer. We discuss the challenges associated with their use and the potential future developments in this exciting area of medicine.

Citation: Ahemad KI (2023) Harnessing the Power of Cytokine Inhibitors: ABreakthrough in Immunotherapy. J Cytokine Biol 8: 463. Doi: 10.4172/2576-3881.1000463

Copyright: © 2023 Ahemad KI. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top